Structure of a cannabinoid receptor and functional expression of the cloned cDNA
The DOI matches its Crossref record; 19 of the 20 references it cites were found in a registry or an index.
Abstract
Marijuana and many of its constituent cannabinoids influence the central nervous system (CNS) in a complex and dose-dependent manner. Although CNS depression and analgesia are well documented effects of the cannabinoids, the mechanisms responsible for these and other cannabinoid-induced effects are not so far known. The hydrophobic nature of these substances has suggested that cannabinoids resemble anaesthetic agents in their action, that is, they nonspecifically disrupt cellular membranes. Recent evidence, however, has supported a mechanism involving a G protein-coupled receptor found in brain and neural cell lines, and which inhibits adenylate cyclase activity in a dose-dependent, stereoselective and pertussis toxin-sensitive manner. Also, the receptor is more responsive to psychoactive cannabinoids than to non-psychoactive cannabinoids. Here we report the cloning and expression of a complementary DNA that encodes a G protein-coupled receptor with all of these properties. Its messenger RNA is found in cell lines and regions of the brain that have cannabinoid receptors. These findings suggest that this protein is involved in cannabinoid-induced CNS effects (including alterations in mood and cognition) experienced by users of marijuana.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The primary psychoactive constituent of cannabis, THC (Mechoulam and Gaoni, 1965), and certain other plant-derived or synthetic psychoactive cannabinoids bind cannabinoid (CB 1 and CB 2 ) receptors (Devane et al, 1988;Matsuda et al, 1990;Munro et al, 1993).”
From The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain (2018) · cites this paper as Matsuda et al, 1990
In the citing paper
“Cannabinoids, like many analgesics and recreational drugs, act on the brain’s reward pathways. Cannabinoid-1 receptors (CB1R) are co-localized with the opioid receptors on the dopaminergic cells of the nucleus accumbens, probably the most important structure in human reward pathways, which partly overlaps the antinociceptive pathways [30–32].”
From Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial (2012) · cites this paper as [30]
In the citing paper
“Both CB12 and CB23 receptors are G-coupled protein receptors that are negatively coupled to adenylate cyclase.”
From Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside (2009) · cites this paper as [2]
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
High-efficiency transformation of mammalian cells by plasmid DNA.
Chen, C., & Okayama, H. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.8.2745 · Cited by 5,373
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
G proteins and dual control of adenylate cyclase
Gilman, A. G. (1984) · Cell · doi:10.1016/0092-8674(84)90336-2 · Cited by 1,802
Identification of a Family of Muscarinic Acetylcholine Receptor Genes
Bonner, T. I., Buckley, N. J., Young, A. C., & Brann, M. R. (1987) · Science · doi:10.1126/science.3037705 · Cited by 1,427
Self-citationA cDNA cloning vector that permits expression of cDNA inserts in mammalian cells.
Okayama, H., & Berg, P. (1983) · Molecular and Cellular Biology · doi:10.1128/mcb.3.2.280 · Cited by 933
Lutropin-Choriogonadotropin Receptor: An Unusual Member of the G Protein-Coupled Receptor Family
McFarland, K. C., Sprengel, R., Phillips, H. S., Köhler, M., Rosemblit, N., Nikolics, K., Segaloff, D. L., & Seeburg, P. H. (1989) · Science · doi:10.1126/science.2502842 · Cited by 929
Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain.
Young, W. S., Bonner, T. I., & Brann, M. R. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.24.9827 · Cited by 743
Self-citationcDNA eloping of bovine substance-K receptor through oocyte expression system
Masu, Y., Nakayama, K., Tamaki, H., Harada, Y., Kuno, M., & Nakanishi, S. (1987) · Nature · doi:10.1038/329836a0 · Cited by 742
Cloning and Sequencing of Porcine LH-hCG Receptor cDNA: Variants Lacking Transmembrane Domain
Loosfelt, H., Misrahi, M., Atger, M., Salesse, R., Vu Hai-Luu Thi, M. T., Jolivet, A., Guiochon-Mantel, A., Sar, S., Jallal, B., Garnier, J., et al. (1989) · Science · doi:10.1126/science.2502844 · Cited by 559
Research works printed but not linked: 14
- Hollister, L. E. Pharmac. Rev. 38, 1–20 (1986).
- Martin, B. R. Pharmac. Rev. 38, 45–74 (1986).
- Dewey, W. L. Pharmac. Rev. 38, 151–178 (1986).
- Howlett, A. C. Molec. Pharmacol. 27, 429–436 (1985).
- Howlett, A. C. & Fleming, R. M. Molec. Pharmacol. 26, 532–538 (1984).
- Howlett, A. C., Qualy, J. M. & Khachatrian, L. L. Molec. Pharmacol. 29, 307–313 (1986).
- Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S. & Howlett, A. C. Molec. Pharmacol. 34, 605–613 (1988).
- Howlett, A. C., Johnson, M. R., Melvin, L. S. & Milne, G. M. Molec. Pharmacol. 33, 297–302 (1988).
- Razdan, R. K. Pharmac. Rev. 38, 75–149 (1986).
- Lawrence, D. K. & Gill, E. W. Molec. Pharmacol. 11, 595–602 (1975).
- Hillard, C. J., Harris, R. A. & Bloom, A. S. J. Pharmac. exp. Ther. 232, 579–588 (1985).
- Okayama, H. & Berg, P. Molec. cell. Biol. 3, 280–289 (1983).
- Chen, C. & Okayama, H. Molec. cell. Biol. 7, 2745–2752 (1987).
- Brooker, G., Harper, J. F., Terasaki, W. L. & Moylan, R. D. Adv. Cyclic Nucleotide Res. 10, 1–33 (1979).
Cited by
Items 801–900 of 1,050
The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?
Moreno, E., Cavic, M. R., Krivokuća, A., Casadó, V., & Canela, E. I. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00339 · Cited by 133
Whan, L., West, M. C. L., McClure, N., & Lewis, S. E. M. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.08.027 · Cited by 150
Soyka, M., Koller, G., Schmidt, P., Lesch, O.-M., Leweke, M., Fehr, C., Gann, H., & Mann, K. F. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318172b8bc · Cited by 126
Δ9-THC stimulates food intake in Lewis rats: effects on chow, high-fat and sweet high-fat diets
Koch, J. E. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00467-1 · Cited by 138
Di Filippo, C., Rossi, F., Rossi, S., & D’Amico, M. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0703303 · Cited by 128
Cichewicz, D. L., Martin, Z. L., Smith, F. L., & Welch, S. P. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38212-6 · Cited by 60
More surprises lying ahead. The endocannabinoids keep us guessing
Piomelli, D. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.07.026 · Cited by 128
Mailleux, P., Parmentier, M., & Vanderhaeghen, J. J. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90265-9 · Cited by 128
Cannabinoids in the treatment of cancer
Alexander, A., Smith, P. F., & Rosengren, R. J. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.04.005 · Cited by 147
Palmer, S. L., Thakur, G. A., & Makriyannis, A. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00143-3 · Cited by 145
Ghosh, S., Wise, L. E., Chen, Y., Gujjar, R., Mahadevan, A., Cravatt, B. F., & Lichtman, A. H. (2013) · Life Sciences · doi:10.1016/j.lfs.2012.06.020 · Cited by 127
“, CB1 and CB2) receptors (Gerard et al., 1991; Matsuda et al., 1990), the lipid endogenous ligands N-arachidonoylethanolamine (anandamide; AEA) (Devane et al.”
BackgroundKishimoto, Y., & Kano, M. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1236-06.2006 · Cited by 150
Hohmann, A. G., Tsou, K., & Walker, J. M. (1999) · Journal of Neurophysiology · doi:10.1152/jn.1999.81.2.575 · Cited by 126
Modulation of the serotonin system by endocannabinoid signaling
Haj‐Dahmane, S., & Shen, R. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.02.016 · Cited by 137
The role of the endocannabinoid system in the neuroendocrine regulation of energy balance
Bermudez-Silva, F. J., Cardinal, P., & Cota, D. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111408458 · Cited by 116
Staiano, R. I., Loffredo, S., Borriello, F., Iannotti, F. A., Piscitelli, F., Orlando, P., Secondo, A., Granata, F., Lepore, M. T., Fiorelli, A., et al. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3hi1214-584r · Cited by 123
The endocannabinoid system of the skin. A potential approach for the treatment of skin disorders
del Río, C., Millán, E., García, V., Appendino, G., DeMesa, J., & Muñóz, E. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.08.022 · Cited by 138
A Guide to Targeting the Endocannabinoid System in Drug Design
Stasiulewicz, A., Znajdek, K., Grudzień, M. K., Pawiński, T., & Sulkowska, J. I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082778 · Cited by 132
Cannabinoids Decrease the K+M-Current in Hippocampal CA1 Neurons
Schweitzer, P. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-01-00051.2000 · Cited by 128
Agudo, J., Martín, M., Roca, C., Molas, M., Bura, S. A., Zimmer, A., Bosch, F., & Maldonado, R. J. (2010) · Diabetologia · doi:10.1007/s00125-010-1894-6 · Cited by 128
Regulation of Gonadotropin-Releasing Hormone Secretion by Cannabinoids
Gammon, C. M., Freeman, G. M., Xie, W., Petersen, S. L., & Wetsel, W. C. (2005) · Endocrinology · doi:10.1210/en.2004-1672 · Cited by 126
The endocannabinoid system and appetite: relevance for food reward
Jager, G., & Witkamp, R. F. (2014) · Nutrition Research Reviews · doi:10.1017/s0954422414000080 · Cited by 118
de Fonseca, F. R., Cebeira, M., Fernández‐Ruíz, J., Navarro, M. A., & Ramos, J. A. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90329-m · Cited by 126
Search for endogenous ligands of the cannabinoid receptor
Mechoulam, R., Hanuš, L., & Martin, B. R. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90197-x · Cited by 134
Neuroprotective agents: Cannabinoids
Sánchez, A., & García-Merino, A. (2011) · Clinical Immunology · doi:10.1016/j.clim.2011.02.010 · Cited by 132
Review of delta‐8‐tetrahydrocannabinol (Δ 8 ‐THC): Comparative pharmacology with Δ 9 ‐THC
Tagen, M., & Klumpers, L. E. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15865 · Cited by 134
Cannabis and schizophrenia: towards a cannabinoid hypothesis of schizophrenia
Müller-Vahl, K. R., & Emrich, H. M. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.7.1037 · Cited by 125
Kishimoto, S., Gokoh, M., Oka, S., Muramatsu, M., Kajiwara, T., Waku, K., & Sugiura, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301359200 · Cited by 125
Cannabinoids Protect Cells from Oxidative Cell Death: A Receptor-Independent Mechanism
Chen, Y., & Buck, J. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39301-2 · Cited by 126
Endocannabinoid signaling and food addiction
D’Addario, C., Bonaventura, M. V. M. D., Pucci, M., Romano, A., Gaetani, S., Ciccocioppo, R., Cifani, C., & Maccarrone, M. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.08.008 · Cited by 134
Song, Z. H., Slowey, C.-A., Hurst, D. P., & Reggio, P. H. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12547-3 · Cited by 141
Blair, R. E., Deshpande, L. S., Sombati, S., Falenski, K. W., Martin, B. R., & DeLorenzo, R. J. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.100354 · Cited by 131
Hohmann, A. G., Farthing, J. N., Zvonok, A. M., & Makriyannis, A. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.060079 · Cited by 133
Therapeutic potential of cannabis in pain medicine
Hosking, R., & Zajicek, J. (2008) · British Journal of Anaesthesia · doi:10.1093/bja/aen119 · Cited by 138
Mailleux, P., & Vanderhaeghen, J. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90832-r · Cited by 136
Ramesh, D., Ross, G. R., Schlosburg, J. E., Owens, R. A., Abdullah, R. A., Kinsey, S. G., Long, J. Z., Nomura, D. K., Sim‐Selley, L. J., Cravatt, B. F., et al. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.181370 · Cited by 130
Lötsch, J., Weyer‐Menkhoff, I., & Tegeder, I. (2018) · European Journal of Pain · doi:10.1002/ejp.1148 · Cited by 118
CB receptor antagonists for the treatment of nicotine addiction
Cohen, C., Kodas, E., & Griebel, G. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.024 · Cited by 133
Guo, Y., Wang, H., Okamoto, Y., Ueda, N., Kingsley, P. J., Marnett, L. J., Schmid, H. H. O., Das, S. K., & Dey, S. K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500168200 · Cited by 123
Salio, C., Fischer, J., Franzoni, M. F., & Conrath, M. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00584-x · Cited by 137
Chung, Y. C., Bok, E., Huh, S. H., Park, J.-Y., Yoon, S.-H., Kim, S. R., Kim, Y.-S., Maeng, S., Hyun Park, S., & Jin, B. K. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102435 · Cited by 124
Nieri, P., Martinotti, E., Testai, L., Adinolfi, B., Calderone, V., & Breschi, M. C. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02831-5 · Cited by 126
Park, B., Gibbons, H. M., Mitchell, M. D., & Glassa, M. (2003) · Placenta · doi:10.1053/plac.2002.0926 · Cited by 128
Electrical Coupling among Irregular-Spiking GABAergic Interneurons Expressing Cannabinoid Receptors
Galarreta, M., Erdélyi, F., Szabó, G., & Hestrin, S. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3027-04.2004 · Cited by 118
Cannabinoid Modulation of Opiate Reinforcement through the Ventral Striatopallidal Pathway
Caillé, S., & Parsons, L. H. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300848 · Cited by 129
Mechanisms of CB1 receptor signaling: endocannabinoid modulation of synaptic strength
Mackie, K. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803273 · Cited by 144
Membrane Assembly of the Cannabinoid Receptor 1: Impact of a Long N-Terminal Tail
Andersson, H., D’Antona, A. M., Kendall, D. A., von HEIJNE, G., & Chin, C. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.3.570 · Cited by 133
Kearn, C. S., Greenberg, M. J., DiCamelli, R., Kurzawa, K., & Hillard, C. J. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722379.x · Cited by 121
Mailleux, P., & Vanderhaeghen, J. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb09807.x · Cited by 124
CB1 Cannabinoid Receptor Signaling and Biased Signaling
Leo, L. M., & Abood, M. E. (2021) · Molecules · doi:10.3390/molecules26175413 · Cited by 129
Basavarajappa, B. S., Yalamanchili, R., Cravatt, B. F., Cooper, T. B., & Hungund, B. L. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.12.005 · Cited by 130
Galdino, P. M., Nascimento, M. V. M., Florentino, I. F., Lino, R. C., Fajemiroye, J. O., Chaibub, B. A., de Paula, J. R., de Lima, T. C. M., & Costa, É. A. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.04.012 · Cited by 139
Amaya, F., Shimosato, G., Kawasaki, Y., Hashimoto, S., Tanaka, Y., Ji, R.-R., & Tanaka, M. (2006) · Pain · doi:10.1016/j.pain.2006.04.001 · Cited by 120
Cannabinoid Receptors and Their Endogenous Ligands
Sugiura, T., & Waku, K. (2002) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a003200 · Cited by 121
Cannabinoid Transmission and Pain Perception
Martin, B. R., & Lichtman, A. H. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0218 · Cited by 117
Porcella, A., Casellas, P., Gessa, G. L., & Pani, L. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00105-3 · Cited by 134
Endocannabinoid Signaling in the Control of Social Behavior
Wei, D., Allsop, S., Tye, K., & Piomelli, D. (2017) · Trends in Neurosciences · doi:10.1016/j.tins.2017.04.005 · Cited by 109
Cannabinoid receptor CB2 modulates the CXCL12/CXCR4-mediated chemotaxis of T lymphocytes
Ghosh, S. T., Preet, A., Groopman, J. E., & Ganju, R. K. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.01.005 · Cited by 120
Mechanisms of Control of Neuron Survival by the Endocannabinoid System
Galve-Roperh, I., Aguado, T., Palazuelos, J., & Guzman, M. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208785740117 · Cited by 121
Welch, S. P., Huffman, J. W., & Lowe, J. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37725-0 · Cited by 120
Hohmann, A. G., Martin, W. J., Tsou, K., & Walker, J. M. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00196-d · Cited by 134
Smith, T. H., Sim‐Selley, L. J., & Selley, D. E. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00777.x · Cited by 117
Yao, B. B., Mukherjee, S., Fan, Y., Garrison, T. R., Daza, A. V., Grayson, G. K., Hooker, B. A., Dart, M. J., Sullivan, J. P., & Meyer, M. D. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706838 · Cited by 116
Endocannabinoids and neurodegenerative diseases
Micale, V., Mazzola, C., & Drago, F. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.09.008 · Cited by 130
Effect of the cannabinoid receptor agonist WIN55212‐2 on sympathetic cardiovascular regulation
Niederhoffer, N., & Szabó, B. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702337 · Cited by 119
Altered gene expression in striatal projection neurons in CB1 cannabinoid receptor knockout mice
Steiner, H., Bonner, T. I., Zimmer, A. M., Kitai, S. T., & Zimmer, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5786 · Cited by 117
Self-citationCannabinoids: A new hope for breast cancer therapy?
Caffarel, M. M., Andradas, C., Pérez-Gómez, E., Guzmán, M., & Sánchez, C. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.06.005 · Cited by 134
The Cannabinoid Receptor 2 Is Critical for the Host Response to Sepsis
Tschöp, J., Kasten, K. R., Nogueiras, R., Goetzman, H. S., Cave, C. M., England, L. G., Dattilo, J. R., Lentsch, A. B., Tschöp, M. H., & Caldwell, C. C. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900203 · Cited by 119
Haemodynamic profile and responsiveness to anandamide of TRPV1 receptor knock‐out mice
Pacher, P., Bátkai, S., & Kunos, G. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.064824 · Cited by 119
Comparative biology of the endocannabinoid system: Possible role in the immune response
Salzet, M., Breton, C., Bisogno, T., & Marzo, V. D. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01550.x · Cited by 130
Endocannabinoids and cannabinoid receptor genetics
Onaivi, E. S., Leonard, C. M., Ishiguro, H., Zhang, P. W., Lin, Z., Akinshola, B. E., & Uhl, G. R. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00007-2 · Cited by 126
Endocannabinoids in the immune system and cancer.
Parolaro, D., Massi, P., Rubino, T., & Monti, E. (2002) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0355 · Cited by 137
Kinsey, S. G., Long, J. Z., Cravatt, B. F., & Lichtman, A. H. (2010) · The Journal of Pain · doi:10.1016/j.jpain.2010.04.001 · Cited by 118
Endocannabinoids and the Immune System in Health and Disease
Cabral, G. A., Ferreira, G. A., & Jamerson, M. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-20825-1_6 · Cited by 119
Griffin, G., Atkinson, P. J., Showalter, V. M., Martin, B. R., & Abood, M. E. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37418-x · Cited by 140
Braida, D., Pozzi, M., Parolaro, D., & Sala, M. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00766-x · Cited by 118
Cannabinoid (CB1) Receptor Activation Inhibits Trigeminovascular Neurons
Akerman, S., Holland, P. R., & Goadsby, P. J. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.106971 · Cited by 122
Balerio, G. N., Aso, E., Berrendero, F., Murtra, P., & Maldonado, R. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03714.x · Cited by 115
Xu, H., Cheng, C. L., Chen, M., Manivannan, A., Cabay, L., Pertwee, R. G., Coutts, A., & Forrester, J. V. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0307159 · Cited by 116
Gelfand, E. V., & Cannon, C. P. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.12.067 · Cited by 132
Efficacy and safety of medical cannabinoids in older subjects: A systematic review
van den Elsen, G. A. H., Ahmed, A. I. A., Lammers, M. W., Kramers, C., Verkes, R., van der Marck, M. A., & Rikkert, M. G. M. O. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.01.007 · Cited by 130
Emerging class of omega-3 fatty acid endocannabinoids & their derivatives
Watson, J. E., Kim, J. S., & Das, A. (2019) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2019.106337 · Cited by 126
Pharmacological and therapeutic secrets of plant and brain (endo)cannabinoids
Hanuš, L. O. (2009) · Medicinal Research Reviews · doi:10.1002/med.20135 · Cited by 109
Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices
Ameri, A., Wilhelm, A., & Simmet, T. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702478 · Cited by 117
What we know and do not know about the cannabinoid receptor 2 (CB2)
Malfitano, A. M., Basu, S., Maresz, K., Bifulco, M., & Dittel, B. N. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.04.002 · Cited by 112
Esfandyari, T., Camilleri, M., Ferber, I., Burton, D., Baxter, K., & Zinsmeister, A. R. (2006) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2006.00834.x · Cited by 115
Murillo-Rodriguez, E., Blanco-Centurion, C., Sanchez, C., Daniele, P., & Shiromani, P. J. (2003) · Sleep · doi:10.1093/sleep/26.8.943 · Cited by 115
Bramblett, R. D., Panu, A. M., Ballesteros, J. A., & Reggio, P. H. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00178-9 · Cited by 117
Booker, L., Kinsey, S. G., Abdullah, R. A., Blankman, J. L., Long, J. Z., Ezzili, C., Boger, D. L., Cravatt, B. F., & Lichtman, A. H. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01445.x · Cited by 116
Lipid metabolism in astrocytic structure and function
Lee, J. A., Hall, B., Allsop, J., Alqarni, R., & Allen, S. P. (2021) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2020.07.017 · Cited by 116
Effects of Cannabinoids on T-cell Function and Resistance to Infection
Eisenstein, T. K., & Meissler, J. J. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9603-3 · Cited by 122
Edgemond, W. S., Hillard, C. J., Falck, J. R., Kearn, C. S., & Campbell, W. B. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.1.180 · Cited by 116
Calcium Dependence of Retrograde Inhibition by Endocannabinoids at Synapses onto Purkinje Cells
Brenowitz, S. D., & Regehr, W. G. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-15-06373.2003 · Cited by 116
Luongo, L., Palazzo, E., Tambaro, S., Giordano, C., Gatta, L., Scafuro, M. A., Rossi, F. S., Lazzari, P., Pani, L., de Novellis, V., et al. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.09.021 · Cited by 114
McCoy, K. L., Matveyeva, M., Carlisle, S. J., & Cabral, G. A. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38313-2 · Cited by 115
Treatment of marijuana dependence: a review of the literature.
McRae, A. L., Budney, A. J., & Brady, K. T. (2003) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(03)00041-2 · Cited by 115
“Recent research indicates that the CB1 receptor is involved in the behavioral, psychomotor, cardiovascular, and cognitive effects of marijuana (Ledent et al., 1999; Matsuda, Lolait, Brownstein, Young, & Bonner, 1990; Munro, Thomas, & Abu-Shaar, 1993).”
BackgroundHuang, H., Acuna-Goycolea, C., Li, Y., Cheng, H. M., Obrietan, K., & van den Pol, A. N. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0732-07.2007 · Cited by 112
Hwang, S. H., Shin, T., Choi, S.-H., Cho, H., Lee, B.-H., Pyo, M. K., Lee, J., Kang, J., Kim, H., Park, C.-W., et al. (2012) · Molecules and Cells · doi:10.1007/s10059-012-2216-z · Cited by 115
The peripheral cannabinoid receptor knockout mice: an update
Buckley, N. E. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707527 · Cited by 113
Basavarajappa, B. S., Saito, M., Cooper, T. B., & Hungund, B. L. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01557-7 · Cited by 115
Metadata
- Authors
- Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I.
- Affiliations
- National Institutes of Health (US)
- ORCID
- Lolait, Stephen J.
- Venue
- Nature
- Published
- 1990-08-09
- Volume
- 346
- Issue
- 6284
- Pages
- 561-564
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2075894678
- Cited by
- 5,011
- References
- 20
- Citations by year
- 2026: 47 · 2025: 84 · 2024: 105 · 2023: 141 · 2022: 129 · 2021: 205 · 2020: 185 · 2019: 171 · 2018: 153 · 2017: 169 · 2016: 172 · 2015: 176 · 2014: 184 · 2013: 190 · 2012: 200
- FWCI
- 53.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- cannabinoid receptors, G protein-coupled receptors, cDNA cloning, receptor structure, adenylate cyclase inhibition, pertussis toxin sensitivity, cannabis, central nervous system effects, brain mRNA expression
- MeSH terms
- Cyclic AMP, Amino Acid Sequence, Animals, Base Sequence, Binding, Competitive, Cannabinoids, Cell Line, Cerebral Cortex, Cloning, Molecular, Colforsin, Kinetics, Molecular Sequence Data, Receptors, Drug, Transfection, Gene Library, Receptors, Cannabinoid, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.